HOSPITAL UNIVERSITARIO RUBER
Departamento
University of Modena and Reggio Emilia
Módena, ItaliaPublicaciones en colaboración con investigadores/as de University of Modena and Reggio Emilia (3)
2024
-
Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer
Cancer Treatment Reviews, Vol. 128
2020
-
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
The Lancet Oncology, Vol. 21, Núm. 11, pp. 1455-1464
2015
-
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): A randomised, open-label, multicentre, phase 2 trial
The Lancet Oncology, Vol. 16, Núm. 16, pp. 1700-1710